Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 17 studies | 30% ± 9% | |
| lung | 16 studies | 35% ± 13% | |
| brain | 10 studies | 28% ± 9% | |
| intestine | 9 studies | 29% ± 13% | |
| eye | 9 studies | 26% ± 11% | |
| kidney | 8 studies | 28% ± 9% | |
| liver | 6 studies | 34% ± 20% | |
| bone marrow | 5 studies | 28% ± 9% | |
| lymph node | 5 studies | 32% ± 10% | |
| pancreas | 4 studies | 43% ± 16% | |
| uterus | 4 studies | 44% ± 14% | |
| breast | 4 studies | 29% ± 3% | |
| placenta | 3 studies | 39% ± 5% | |
| skin | 3 studies | 17% ± 1% | |
| thymus | 3 studies | 45% ± 20% | |
| prostate | 3 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 4773.49 | 459 / 459 | 100% | 57.83 | 1118 / 1118 |
| esophagus | 100% | 3174.74 | 1443 / 1445 | 100% | 37.58 | 183 / 183 |
| brain | 100% | 3365.15 | 2638 / 2642 | 100% | 51.25 | 705 / 705 |
| ovary | 100% | 3958.04 | 180 / 180 | 100% | 44.02 | 429 / 430 |
| lung | 100% | 3071.51 | 576 / 578 | 100% | 50.37 | 1155 / 1155 |
| uterus | 100% | 3774.55 | 170 / 170 | 100% | 55.51 | 457 / 459 |
| thymus | 100% | 3772.50 | 653 / 653 | 100% | 53.17 | 602 / 605 |
| prostate | 100% | 3361.22 | 245 / 245 | 99% | 50.08 | 499 / 502 |
| bladder | 100% | 3491.05 | 21 / 21 | 99% | 50.96 | 499 / 504 |
| stomach | 100% | 2476.65 | 359 / 359 | 98% | 46.98 | 281 / 286 |
| intestine | 100% | 3397.55 | 966 / 966 | 98% | 52.80 | 516 / 527 |
| adrenal gland | 100% | 3896.67 | 258 / 258 | 97% | 36.32 | 224 / 230 |
| kidney | 100% | 2871.99 | 89 / 89 | 97% | 31.51 | 872 / 901 |
| pancreas | 97% | 1376.05 | 318 / 328 | 99% | 40.97 | 176 / 178 |
| liver | 99% | 1689.32 | 223 / 226 | 97% | 24.69 | 393 / 406 |
| skin | 100% | 4434.50 | 1804 / 1809 | 95% | 46.86 | 450 / 472 |
| blood vessel | 100% | 4679.58 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 48.61 | 29 / 29 |
| spleen | 100% | 3163.00 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 38.15 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 30.12 | 1 / 1 |
| adipose | 100% | 5393.09 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2268.26 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 2318.51 | 831 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 79% | 19.30 | 63 / 80 |
| peripheral blood | 45% | 1678.41 | 416 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1903608 | Biological process | protein localization to cytoplasmic stress granule |
| GO_0042780 | Biological process | tRNA 3'-end processing |
| GO_0008334 | Biological process | histone mRNA metabolic process |
| GO_0006409 | Biological process | tRNA export from nucleus |
| GO_0001682 | Biological process | tRNA 5'-leader removal |
| GO_0006400 | Biological process | tRNA modification |
| GO_0008033 | Biological process | tRNA processing |
| GO_0045727 | Biological process | positive regulation of translation |
| GO_0075522 | Biological process | IRES-dependent viral translational initiation |
| GO_0071045 | Biological process | nuclear histone mRNA catabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0000781 | Cellular component | chromosome, telomeric region |
| GO_1990904 | Cellular component | ribonucleoprotein complex |
| GO_0010494 | Cellular component | cytoplasmic stress granule |
| GO_0005634 | Cellular component | nucleus |
| GO_1990825 | Molecular function | sequence-specific mRNA binding |
| GO_0003729 | Molecular function | mRNA binding |
| GO_0008266 | Molecular function | poly(U) RNA binding |
| GO_0003723 | Molecular function | RNA binding |
| GO_0000049 | Molecular function | tRNA binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SSB |
| Protein name | Small RNA binding exonuclease protection factor La Autoantigen La Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) |
| Synonyms | |
| Description | FUNCTION: Binds to the 3' poly(U) terminus of nascent RNA polymerase III transcripts, protecting them from exonuclease digestion and facilitating their folding and maturation . In case of Coxsackievirus B3 infection, binds to the viral internal ribosome entry site (IRES) and stimulates the IRES-mediated translation . . |
| Accessions | ENST00000409333.1 E9PFL9 E7ERC4 ENST00000417292.5 B5BUB5 ENST00000422006.5 ENST00000413002.5 E9PGX9 P05455 ENST00000260956.9 |